key: cord-1002153-ycaiaqpj authors: Son, Hee-Kyoung; Xiang, Huo; Park, Seohyun; Lee, Jisu; Lee, Jae-Joon; Jung, Sunyoon; Ha, Jung-Heun title: Partial Replacement of Dietary Fat with Polyunsaturated Fatty Acids Attenuates the Lipopolysaccharide-Induced Hepatic Inflammation in Sprague-Dawley Rats Fed a High-Fat Diet date: 2021-10-19 journal: Int J Environ Res Public Health DOI: 10.3390/ijerph182010986 sha: 4a222bc726f62b58f95883d31afe378fd09b7086 doc_id: 1002153 cord_uid: ycaiaqpj In this study, we investigated whether the partial replacement of dietary fat with polyunsaturated fatty acids (PUFAs) ameliorated the lipopolysaccharide (LPS)-induced hepatic inflammation in rats fed a high-fat diet. Male Sprague-Dawley rats were divided into three groups and provided each of the following diets: (1) high-fat diet (HFD), (2) HFD with perilla oil (PO), and (3) HFD with corn oil (CO). After 12 weeks of dietary intervention, the rats were intraperitoneally injected with LPS (5 mg/kg) from Escherichia coli O55:B5 or phosphate-buffered saline (PBS). Following LPS stimulation, serum insulin levels were increased, while PO and CO lowered the serum levels of glucose and insulin. In the liver, LPS increased the triglyceride levels, while PO and CO alleviated the LPS-induced hepatic triglyceride accumulation. In the LPS injected rats, the mRNA expression of genes related to inflammation and endoplasmic reticulum (ER) stress was attenuated by PO and CO in the liver. Furthermore, hepatic levels of proteins involved in the nuclear factor kappa-light-chain-enhancer of activated B cells/mitogen-activated protein kinase pathways, antioxidant response, and ER stress were lowered by PO- and CO-replacement. Therefore, the partial replacement of dietary fat with PUFAs alleviates LPS-induced hepatic inflammation during HFD consumption, which may decrease metabolic abnormalities. Obesity is defined as the accumulation of excess body fat, which may have adverse effects on health [1] . Obesity increases the risk of various metabolic complications, including type 2 diabetes, heart disease, and cardiovascular diseases [2, 3] . In addition, nonalcoholic fatty liver disease (NAFLD) is becoming the most common cause of chronic liver disease due to the increasing prevalence of obesity [4] . Steatosis, a hallmark of NAFLD, occurs when hepatic fatty acid uptake increases due to high energy intake [4] . Previous studies have shown that it contributes to systemic insulin resistance and inflammatory responses, which may occur in obesity [5] . The probability of developing hepatic fibrosis and hepatocellular carcinoma is greater in individuals with steatohepatitis. Lipopolysaccharide (LPS) is considered a potent inducer of hepatic inflammation in experimental rodents [6, 7] . LPS is reported to be the predominant cause of hepatic neutrophil infiltration in steatohepatitis patients [6] . To date, a few studies have examined how obese mouse models respond to acute inflammatory stimuli. They have revealed that, in response to LPS stimulation, three different diets: (1) high-fat diet (HFD), (2) HFD + perilla oil (HFD + PO), and (3) HFD + corn oil (HFD + CO). PO (CJ Cheil Jedang Co., Seoul, Korea) and CO (CJ Cheil Jedang Co.) were purchased from a local market and stored at −20 • C. The amounts of PO and CO added were determined to meet human requirements for n-3 and n-6 PUFAs by converting animal intake into human intake [31, 32] . The experimental diets were formulated based on the AIN-93G diet with slight modification [33] . The constant and variable compositions of each experimental diet are presented in Tables 1 and 2, respectively. After 12 weeks of dietary intervention, the experimental rats were intraperitoneally injected with either phosphate-buffered saline (PBS) or 5 mg/kg of LPS (Escherichia coli, O55:B5; Sigma-Aldrich, St. Louis, MO, USA) under overnight fasting conditions. Next, the experimental rats were euthanized by carbon dioxide (CO 2 ) exposure followed by cervical dislocation. Whole blood was collected by cardiac puncture, maintained at room temperature for 30 min, and centrifuged (3000× g, 15 min) to obtain serum. Liver and multiple white adipose tissue (WAT) fat pads were harvested, weighed, and snap-frozen quickly in liquid nitrogen. Serum and tissue samples were stored in a deep freezer set at −70 • C for further analysis. 1 AIN-93G Mineral mix [33] . 2 AIN-93 Vitamin mix [33] . 1 Unsalted pure butter (Anchor brand, Fonterra Ltd., Hamilton, New Zealand). Abbreviations: HFD, high-fat diet; HFD + PO, high-fat diet + perilla oil; HFD + CO, high-fat diet + corn oil. The fatty acid composition of the experimental diets was assessed by methyl esterification of boron trifluoride (BF 3 )-methanol [34] . First, dietary samples (~0.1 g) were added to a test tube, followed by hexadecanoic acid (C17:0) (0.5 mL, 1 mg/mL hexane). Then, 0.5 N NaOH-methanol (2 mL) was added, and the mixture was heated for 10 min at 110 • C with a heating/stirring module (Thermo Fisher Scientific, Waltham, MA, USA) using Reacti-Therm III. The mixture was then cooled to room temperature, with the subsequent addition of BF 3 -methanol (4 mL). The mixture was heated at 110 • C for 1 h and then cooled. Next, hexane (2 mL) was added, and the mixture was stirred for 1 min, and the hexane layer was collected for lipid analysis. For detection, a gas chromatography (GC) flame ionization detector (FID) with an Agilent Technologies 6890 N instrument was employed, and helium was used as the carrier gas (2.7 mL/min) with an SP-2560 capillary column (Agilent Technologies, Santa Clara, CA, USA). The temperature of the sample injector and detector was set to 250 • C, and the splitting ratio was set to 50:1. The flow rates of air and hydrogen ionized by the flame were 450 and 40 mL/min, respectively. The initial temperature of the oven was set to 130 • C for 5 min. The temperature was then increased by 4 • C/min up to 240 • C and continued for 15 min. All analyses were conducted in triplicate. The results were evaluated by comparing with the standard fatty acid reference (Supelco 37 FAME; Sigma-Aldrich, Sigma-Aldrich, St. Louis, MO, USA). OGTT was conducted at weeks 3, 7, and 11. The day before the OGTT, the rats were fasted overnight. During the fasting period, only drinking water was provided. Animals were orally administered glucose (1 g/kg body weight) by tube feeding, and blood glucose levels were measured by drawing blood from the tail vein and then using a blood glucose meter (Accu-Chek; Roche Diagnostics, Basel, Switzerland). Subsequently, the rat blood glucose levels were measured at 0, 15, 30, 60, and 120 min. The fatty acid composition of whole blood was measured in three pooled samples due to the sample volume limitations. Samples collected from two to three animals in each group were included in any one pool. To ensure that no individual sample greatly influenced the pooled results, the sample volume of whole blood collected from each animal was of equal. For the analysis of the fatty acid composition, a drop of whole blood samples was spiked on a blood-spot card pre-coated with an antioxidant mixture. The card was purchased from OmegaQuant (Sioux Falls, SD, USA). The blood fatty acid composition was analyzed by gas chromatography (GC) as described by Jackson et al. [35] . The fatty acid composition was expressed as a percentage of the total identified fatty acids. The serum levels of triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were measured using commercial kits (Embiel, Gunpo, Korea). To obtain the non-HDL-C level, we subtracted HDL-C levels from the TC level. The atherogenic coefficient (AC) was calculated using the following formula: AC = TC − HDL-C/HDL-C and the cardiac risk factor (CRF) was calculated using the following formula: CRF = TC/HDL-C [36] . Serum glucose levels were analyzed using a rat glucose test kit (Crystal Chem, Downers Grove, IL, USA), and serum insulin levels were analyzed using an enzyme-linked immunosorbent assay (ELISA) reagent kit (Mercodia, Uppsala, Sweden). The homeostasis model assessment-estimated insulin resistance (HOMA-IR) value was calculated as follows: HOMA-IR = fasting insulin in µU/L × fasting glucose in mg/dL/405 [37] . Serum leptin levels were determined using the MILIPLEX map Luminex assay (Millipore, Burlington, MA, USA). Hepatic and epididymal adipose tissue (EAT) lipids were extracted using the method described by Bligh and Dyer methods [38] , with slight modifications. The concentrations of TG and TC were determined using commercial kits (Embiel), and the results were expressed as mg per g of tissue weight. Total RNA was isolated from liver tissue using NucleoZoL Reagent (Macherey-Nagel, GmbH & Co. KG, Düren, Germany) and DNA-free™ Kit (Thermo Fisher Scientific). The isolated RNA was quantitatively analyzed using a SpectraDrop™ Micro-Volume Microplate (SpectraMax iD3; Molecular Devices, San Jose, CA, USA). Next, cDNA was synthesized from 1 µg of total RNA using the iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA), with the T100 Thermal Cycler (Bio-Rad Laboratories) set to priming (25 • C, 5 min), reverse transcription (46 • C, 20 min), RT inactivation (95 • C, 1 min), and then diluted twice with the Ambion™ Nuclease-Free Water (Thermo Fisher Scientific). qRT-PCR was performed using the CFX Connect Real-Time PCR Detection System (Bio-Rad Laboratories). The primer sequences used in this study are listed in Table 3 . The cDNA sample (2 µL), 10 µM forward primer (Macrogen, Seoul, Korea) (1 µL), 10 µM reverse primer (Macrogen) (1 µL), Ambion™ Nuclease-Free Water (5 µL), 2× PCR Master Mix (10 µL), 20× SFCGreen ® I Dye (BioFACT, Daejeon, Korea) (1 µL), and mixture at a final total volume of 20 µL were injected into each well of Multiplate™ 96-Well PCR plates (Bio-Rad Laboratories). Then, a Microseal 'B' PCR plate sealing film (Bio-Rad Laboratories) was affixed before the reaction. DNA denaturation (95 • C, 3 min) was performed for polymerase activation by thermal cycling. Subsequently, denaturation (95 • C, 10 s), annealing/extension (55 • C, 30 s), and the plate read were set, and go to 2 was performed in a circular fashion (49 times). After completion of the reaction, quantitative analysis was performed using CFX Maestro (Bio-Rad Laboratories). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a housekeeping gene, was used as the internal control [39] . The expression level of GAPDH did not significantly vary between the groups. The relative mRNA level (fold change) was calculated and compared with that of the HFD control group. Liver tissue was homogenized using an ultrasonic cell disruptor (Branson Sonifier ® ; Branson, Danbury, CT, USA) with a mixture of ice-cold radioimmunoprecipitation assay (RIPA) lysis buffer (ATTO, Japan) 99: Halt™ Protease and Phosphatase Inhibitor Single-Use Cocktail 100× (Thermo Fisher Scientific) 1, followed by slow stirring at 4 • C (2 h) and centrifugation at 16,000× g at 4 • C for 20 min. Total protein lysates were collected from the supernatants. The protein content of the extract was determined using a Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific). Based on the obtained results, a 30 µg/µL protein mixture was prepared by mixing sodium dodecyl sulfate (SDS) loading buffer 5× (6 µL) and distilled water with the extract. The proteins were separated by 10-12% SDSpolyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto a polyvinylidene difluoride (PVDF) membrane (Bio-Rad Laboratories). The membrane was blocked with 5% skim milk (Becton-Dickinson, Franklin Lakes, NJ, USA) and incubated at 4 • C overnight with primary antibodies, followed by incubation with the corresponding secondary antibodies. The antibodies used for Western blotting are presented in Table 4 . Finally, the samples were stained with SuperSignal™ West Pico PLUS Chemiluminescent Substrate (Thermo Fisher Scientific), scanned using Chemidoc (Davinch-Western™ Imaging system; Davinch-K, Seoul, Korea) for graphical results, and then quantitatively analyzed using the Image J Software v.1.8 (National Institutes of Health, Bethesda, MD, USA). β-Actin was used as an internal control. Finally, the protein expression level (fold change) was calculated by comparing the HFD and control groups. Abbreviations: IkBα, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; JNK, c-Jun N-terminal kinases; ERK, extracellular signal-regulated kinases; Nrf2, nuclear factor erythroid 2-related factor 2; HO-1, heme oxygenase 1; BiP, binding immunoglobulin protein; CHOP, C/EBP homologous protein. Values are expressed as the mean ± standard deviation (SD) or Box-and-Whisker-plots. Graphs were prepared using GraphPad Prism 5 for Windows (GraphPad Software Inc., San Diego, CA, USA). Data were analyzed using one-or two-way analysis of variance (ANOVA), followed by Tukey's post hoc test using XLSTAT 2012 for windows (Addinsoft Inc., Paris, France). Statistical significance was set at p < 0.05. A summary of the statistical results of the two-way ANOVA for main effects and interactions is presented in Table 5 . Table 5 . Summary of statistical analysis by two-way analysis of variance (ANOVA) for main effects and interactions. Serum glucose, insulin, and leptin levels Glucose **** p < 0.0001 **** p < 0.0001 * p < 0.05 Insulin **** p < 0.0001 ** p < 0.01 ** p < 0.01 HOMA-IR **** p < 0.0001 **** p < 0.0001 **** p < 0.0001 Serum leptin **** p < 0.0001 ns p = 0.328 ns p = 0.332 Serum lipid profile Triglyceride **** p < 0.0001 *** p < 0.001 **** p < 0.0001 Total cholesterol **** p < 0.0001 **** p < 0.0001 *** p < 0.001 HDL-cholesterol **** p < 0.0001 ns p = 0.191 ns p = 0.573 Non-HDL-cholesterol **** p < 0.0001 **** p < 0.0001 **** p < 0.0001 Atherogenic coefficient **** p < 0.0001 ** p < 0.01 * p < 0.05 Cardiac risk factor **** p < 0.0001 ** p < 0.01 * p < 0.05 Hepatic function parameters Serum AST **** p < 0.0001 **** p < 0.0001 **** p < 0.0001 Serum ALT **** p < 0.0001 **** p < 0.0001 **** p < 0.0001 Serum ALP **** p < 0.0001 **** p < 0.0001 **** p < 0.0001 Lipid contents in liver and epididymal adipose tissue Hepatic triglyceride **** p < 0.0001 **** p < 0.0001 **** p < 0.0001 Hepatic total cholesterol **** p < 0.0001 *** p < 0.001 ns p = 0.846 EAT triglyceride ns p = 0.160 **** p < 0.0001 **** p < 0.0001 EAT total cholesterol * p < 0.05 **** p < 0.0001 **** p < 0.0001 * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant. Abbreviations: WAT, white adipose tissue; EAT, epididymal adipose tissue; MAT, mesenteric adipose tissue; RAT, retroperitoneal adipose tissue; PAT, perirenal adipose tissue; HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; CXCL-1, chemokine (C-X-C motif) ligand 1; IL-1β, interleukin 1β; BiP, binding immunoglobulin protein; CHOP, C/EBP homologous protein. The fatty acid composition of the experimental diets is presented in Table 6 . The saturated fatty acid (SFA) content was high in the order of HFD, HFD + PO, and HFD + CO groups, but the MUFA content was lower in the HFD group than in the HFD + PO and HFD + CO groups. On the other hand, the PUFA content was high in the order of HFD + CO, HFD + PO, and HFD groups. Among them, the n-6 fatty acid content was the highest in the HFD + CO group, whereas the n-3 fatty acid content was the highest in the HFD + PO group. Due to the high content of n-3 fatty acids, the n-6/n-3 ratio of HFD + PO (0.95) was considerably lower than that of HFD + CO (62.24). Abbreviations: HFD + PO, high-fat diet + perilla oil; HFD + CO, high-fat diet + corn oil; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; TFA, trans-fatty acids; PUFA, polyunsaturated fatty acids;